Public Health Clinical Center of Chengdu Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2016
NCT02901288
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 4)

Tuberculosis, Pulmonary (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 5